Mutated Alpha-Synuclein Seeding Assay for Rapid Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting misfolded α-Synuclein (αSyn) in biological samples are slow and lack sensitivity, hindering early diagnosis of synucleinopathies such as Parkinson's disease, with existing assays requiring 5 to 13 days and showing variable diagnostic accuracy.
Innovation Solution
A rapid αSyn RT-QuIC assay using specific mutated recombinant alpha synuclein (rαSyn) substrates is developed, which involves contacting a biological sample with soluble mutated rαSyn, promoting coaggregation of misfolded αSyn aggregates, and detecting these aggregates through agitation and fluorescence, allowing for quick and sensitive detection of misfolded αSyn.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If conventional αSyn detection methods are used, then diagnostic accuracy can be achieved, but the assay time is slow (5-13 days)
Solution Approach 1:
The patent modifies the assay parameters by using mutated recombinant αSyn substrates with specific amino acid changes (e.g., A53T, E46K) that accelerate aggregation kinetics. This parameter change in substrate structure enables the assay to complete in 24-48 hours rather than 5-13 days, directly resolving the time loss issue while maintaining diagnostic accuracy
Solution Approach 2:
The patent implements periodic agitation cycles during the incubation period, alternating between resting periods and agitation phases. This periodic action promotes continuous seed formation and substrate conversion, significantly accelerating the detection process and reducing assay time without compromising sensitivity
2Measurement precision
If conventional immunoassays for αSyn in CSF are used, then diagnosis can be attempted, but sensitivity and diagnostic utility are insufficient
Solution Approach 1:
The patent replaces conventional immunoassay mechanisms with a seeding-based aggregation assay. Instead of detecting αSyn through antibody binding, the system uses misfolded αSyn seeds to induce conformational conversion of soluble substrate, detecting the process through fluorescence. This substitution dramatically improves both sensitivity and diagnostic accuracy
Solution Approach 2:
The patent employs fluorescence-based detection that monitors color/fluorescence changes as soluble substrate converts to aggregated form during the seeding process. This optical detection method provides high sensitivity and specific signals that enable accurate diagnosis, overcoming the limitations of conventional immunoassays
3Speed
If mutated recombinant αSyn substrates are used in RT-QuIC assay, then detection speed increases (24-48 hours), but assay complexity increases
Solution Approach 1:
The patent segments the detection system into distinct functional components: mutated recombinant αSyn substrates, seeding mechanism, incubation system, and fluorescence detection. This segmentation allows each component to be optimized independently, achieving rapid detection while managing complexity through modular design
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables rapid detection of misfolded αSyn with high sensitivity and specificity, facilitating early diagnosis of synucleinopathies within 24-48 hours, improving diagnostic accuracy and enabling monitoring of therapeutic effects.
Implementation Method 1
incubating the reaction mixture to permit coaggregation of misfolded αSyn aggregates present in the biological sample, or fraction thereof, with the mutated rαSyn
Implementation Method 2
detecting these aggregates through agitation and fluorescence
Data Source
AI summary
Methods are disclosed for determining whether a subject has a synucleinopathy. Methods are also disclosed for detecting misfolded alpha synuclein (αSyn) in a biological sample or fraction thereof. These methods include the use of an αSyn seeding assay.